Business
AstraZeneca vaccine approved for use in Australia, CSL (ASX:CSL) share price up
The CSL Limited (ASX: CSL) share price climbed 2% today after the AstraZeneca – Oxford University COVID-19 vaccine was approved for use in Australia.
According to reporting by the Australian Financial Review, the provisional approval will mean that adults who are 18 or older will be able to take two doses of the drug, between four to twelve weeks apart.
The Australian federal government has ordered almost 54 million doses of the vaccine, with CSL to start manufacturing within the country from the end of next month. CSL has been tasked with manufacturing 50 million doses.
One of the main benefits of the Oxford University – AstraZeneca COVID-19 vaccine is that it can be held in normal refrigerators. The Pfizer COVID-19 vaccine…
-
Noosa News20 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News21 hours agoBrisbane-bound traffic diverted after pile-ups along Bruce Highway
-
Noosa News20 hours agoMan arrested after police chase: Driver shot, woman dies in crash
-
General18 hours agoSummah Richards, 12, mourned after fatal e-scooter in Laidley, Queensland